This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Colgate-Palmolive (CL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Colgate-Palmolive (CL) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Albertsons (ACI) Q4 Earnings In Line, Sales Miss Estimates
by Zacks Equity Research
Albertsons (ACI) Q4 results reflect its commitment toward operational excellence, digital expansion, pharmacy operations and customer relationships.
Here's How Colgate (CL) Stock is Poised Ahead of Q1 Earnings
by Zacks Equity Research
Colgate's (CL) first-quarter 2024 performance is likely to gain from solid consumer demand and efforts related to innovation, premiumization and digital transformation.
Colgate (CL) to Retain Earnings Momentum in Q1: Wise to Buy?
by Zacks Equity Research
Colgate's (CL) aggressive pricing actions, along with solid business momentum, supported by robust consumer demand and innovation, should craft its successful earnings story.
Earnings Preview: Clorox (CLX) Q3 Earnings Expected to Decline
by Zacks Equity Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Exploring Analyst Estimates for Colgate-Palmolive (CL) Q1 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Colgate-Palmolive (CL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
Procter & Gamble (PG) Q3 Earnings Top Estimates, Sales Miss
by Zacks Equity Research
Procter & Gamble's (PG) Q3 results gain from sales growth across operating segments, improved organic sales and margin expansion, offset by higher SG&A expenses.
Colgate-Palmolive (CL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inter Parfums (IPAR) Poised on Brand Strength, Expansion Efforts
by Zacks Equity Research
Inter Parfums' (IPAR) product launches, brand extension, expansion through new licenses or acquisitions and solid product demand have been aiding growth.
Colgate-Palmolive (CL) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
The latest trading day saw Colgate-Palmolive (CL) settling at $86.75, representing a +0.67% change from its previous close.
Here's Why PepsiCo (PEP) Looks Poised for Earnings Beat in Q1
by Zacks Equity Research
PepsiCo's (PEP) Q1 results are expected to reflect gains from continued benefits of the mitigation of inflationary pressures through cost-management and revenue-management initiatives.
Are Consumer Staples Stocks Lagging Lancaster Colony (LANC) This Year?
by Zacks Equity Research
Here is how Lancaster Colony (LANC) and Colgate-Palmolive (CL) have performed compared to their sector so far this year.
Will Strategies Help Procter & Gamble (PG) Beat on Q3 Earnings?
by Zacks Equity Research
Procter & Gamble (PG) is progressing well with its pricing actions, business investments, and productivity and cost-saving plans. These are likely to have supported its Q3 performance.
Zacks Industry Outlook Highlights Colgate-Palmolive, Henkel, Church & Dwight and The Clorox
by Zacks Equity Research
Colgate-Palmolive, Henkel, Church & Dwight and The Clorox have been highlighted in this Industry Outlook article.
Beat the Market the Zacks Way: MediaAlpha, NVIDIA, Walmart in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Tyson Foods (TSN) Rises More Than 20% in 6 Months: Here's How
by Zacks Equity Research
Tyson Foods' (TSN) engagement in brand building, innovation and operational enhancements positions it well despite the expected challenges in the Beef segment.
4 Soap & Cleaning Materials Stocks to Watch Amid Favorable Industry Trends
by Rajani Lohia
The soap and cleaning materials industry stays composed, backed by efforts to improve sales, including pricing actions, innovation, digital transformation and brand building, amid elevated costs. Players like CL, HENKY, CHD and CLX look well-poised.
The Zacks Analyst Blog Highlights Colgate-Palmolive, Pilgrim's Pride, Mondelez International, Molson Coors Beverage and Grocery Outlet
by Zacks Equity Research
Colgate-Palmolive, Pilgrim's Pride, Mondelez International, Molson Coors Beverage and Grocery Outlet are part of the Zacks top Analyst Blog.
Will Colgate-Palmolive (CL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
5 Consumer Staples Stocks to Buy on Uncertainty Over Rate Cuts
by Ritujay Ghosh
Stocks like Colgate-Palmolive Company (CL), Pilgrim's Pride Corporation (PPC), Mondelez International, Inc. (MDLZ), Molson Coors Beverage Company (TAP) and Grocery Outlet Holding Corp. (GO) are a safe bet amid the ongoing market volatility.
Pricing Strategy Aids Procter & Gamble (PG): Stock to Gain
by Zacks Equity Research
Procter & Gamble (PG) witnesses strong business momentum, driven by underlying strength in brands and appropriate strategies, which boosts organic sales growth.
Why Colgate-Palmolive (CL) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
Dividend Watch: 3 Companies Boosting Payouts
by Derek Lewis
Companies that consistently boost their dividend payouts reflect a successful and shareholder-friendly nature, opting to share a portion of profits with investors. And that's precisely what these three have done.
Is ColgatePalmolive (CL) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Colgate-Palmolive (CL) and Lancaster Colony (LANC) have performed compared to their sector so far this year.